Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2003
03/27/2003US20030059769 High affinity nucleic acid ligands to lectins
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059764 Apparatus for use in the detection and analysis of preferential cells in sample
03/27/2003US20030059763 Nucleotidesequences coding polypeptide for use as tools in human therapeutics
03/27/2003US20030059443 Polynucleotides comprising molecular interaction sites of hepatitis C virus RNA that have particular secondary structure; for modulating the activity of hepatitis C virus RNA
03/27/2003US20030059433 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030059400 Comprises DNA sequence encoding a detectable, cytotoxic protein or protein capable of inducing a detectable signal (luminescent or fluorescent); tumor imaging; gene expression
03/27/2003US20030059094 Method of extracting locations of nucleic acid array features
03/27/2003US20030058799 Nucleic acid sequencing by raman monitoring of molecular deconstruction
03/27/2003US20030058672 Associative memory circuit judging whether or not a memory cell content matches search data by performing a differential amplification to a potential of a match line and a reference potential
03/27/2003US20030057094 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
03/27/2003CA2708411A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2472023A1 Method for evaluating a patient's biological condition
03/27/2003CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003CA2460845A1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
03/27/2003CA2460817A1 A method for identifying effector molecules for gene network integration
03/27/2003CA2460812A1 Lipid-associated molecules
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460805A1 Nanomachine compositions and methods of use
03/27/2003CA2460771A1 Method for determining the presence of bacteria resistant to cell lysing antibiotics
03/27/2003CA2460721A1 Genetic analysis for stratification of cancer risk
03/27/2003CA2460700A1 Asparagine hydroxylation of the cad domain of a hif protein
03/27/2003CA2460652A1 Compositions and methods to identify haplotypes
03/27/2003CA2460639A1 Engineered templates and their use in single primer amplification
03/27/2003CA2460560A1 Kits and methods for determining the effectiveness of sterilization or disinfection processes
03/27/2003CA2460546A1 Dna polymerases and mutants thereof
03/27/2003CA2460456A1 Chromogenic in situ hybridization methods, kits, and compositions
03/27/2003CA2460317A1 Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
03/27/2003CA2460130A1 Method for detecting sepsis
03/27/2003CA2460128A1 Bbc3 gene promoter and methods for identifying modulators of apoptosis and bbc3 gene expression using a bbc3 gene promoter
03/27/2003CA2460073A1 Embossed test strip system
03/27/2003CA2459972A1 Differential diagnosis of disorders of iron metabolism by means of three independent parameters and recommendations for the treatment of these disorders of iron metabolism
03/27/2003CA2459761A1 Device and method for concentration and detection of pathogenic germs from blood products and/or their derivatives
03/27/2003CA2459219A1 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2458303A1 Brain expressed cap-2 gene and protein associated with bipolar disorder
03/27/2003CA2452288A1 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003CA2445205A1 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/27/2003CA2423849A1 Method for determining the age of individuals
03/26/2003EP1296334A2 Associative memory with matching circuit with differential amplification
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295952A2 Methods for screening for transdominant effector peptides and RNA molecules
03/26/2003EP1295951A1 Cell library method
03/26/2003EP1295950A1 Expression profiling
03/26/2003EP1295949A1 Dual chamber disposable reaction vessel for amplification reactions, reaction processing station therefor, and methods of use
03/26/2003EP1295948A2 Method of measurement of protease and thin membranes used for said method
03/26/2003EP1295947A1 Method of measuring total homocysteine
03/26/2003EP1295945A1 Human neuronal nictinic acetylcholine receptor compositions and mehtods employing same
03/26/2003EP1295944A2 GDP dissociation stimulating protein, brain-specific nucleosome assembly protein, skeletal muscle specific ubiquitin-conjugating enzyme, cell proliferation protein, phosphatidylinositolkinase, nel related proteins
03/26/2003EP1295941A1 Novel nucleic acid probes and method of assaying nucleic acid by using the same
03/26/2003EP1295896A1 Method for identifying or isolating a molecule and molecules identified thereby
03/26/2003EP1295643A1 Liquid droplet ejecting method and a liquid droplet ejection apparatus
03/26/2003EP1295238A2 Clustering method
03/26/2003EP1295128A2 Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit
03/26/2003EP1295127A2 Inter-alpha-trypsin as a marker for sepsis
03/26/2003EP1294952A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds
03/26/2003EP1294951A2 Diagnosis of diseases associated with the immune system
03/26/2003EP1294950A2 Diagnosis of diseases associated with development genes
03/26/2003EP1294948A2 Diagnosis of behavioural disorders, neurological disorders and cancer
03/26/2003EP1294947A2 Method and nucleic acids for pharmacogenomic methylation analysis
03/26/2003EP1294946A2 Multiplex sequencing method
03/26/2003EP1294945A2 Method for detecting cytosine methylations
03/26/2003EP1294944A2 Detection of nucleic acids by type-specific hybrid capture method
03/26/2003EP1294943A2 RAPID DETERMINATION OF GENE STRUCTURE USING cDNA SEQUENCE
03/26/2003EP1294942A1 Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods
03/26/2003EP1294941A1 Method for i in vitro /i diagnosis of prostatic cancer and kit therefor
03/26/2003EP1294940A2 Polynucleotide probes for detection and quantitation of candida albicans and candida dubliniensis
03/26/2003EP1294939A2 Detection and typing of human papillomavirus using pna probes
03/26/2003EP1294938A2 Cell-binding nucleic acid molecules (aptamers)
03/26/2003EP1294937A2 Beta2 adrenergic receptor polymorphism detection
03/26/2003EP1294936A2 High throughput methods for haplotyping
03/26/2003EP1294935A2 Compositions and methods for simultaneous detection of multiple biological entities
03/26/2003EP1294934A2 Very low density lipoprotein receptor polymorphisms and uses therefor
03/26/2003EP1294933A2 Method for reducing artifacts in nucleic acid amplification
03/26/2003EP1294931A1 Screening methods for gram-positive enterococcal virulence factors
03/26/2003EP1294930A2 Nanoparticles having oligonucleotides attached thereto and uses therefor
03/26/2003EP1294929A1 Method to detect modulators of vegf kinase domain
03/26/2003EP1294928A1 Screening method for modulators of suv39h2-methyltransferase
03/26/2003EP1294927A1 Screening-method for modulators of methyltransferase-dependent chromosome stability
03/26/2003EP1294926A2 Test system for determining the activity of cyclo-nucleotide-dependent protein kinases and vasp phosphatases
03/26/2003EP1294925A2 Phosphoribosyl pyrophosphate synthetase 1 as herbicidal target
03/26/2003EP1294924A2 Method for identifying medically valuable active substances
03/26/2003EP1294923A2 Methods for using mass spectrometry to identify and classify filamentous fungi, yeasts, molds and pollen
03/26/2003EP1294922A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
03/26/2003EP1294909A2 Natural promoters for gene expression and metabolic monitoring in bacillus species
03/26/2003EP1294906A2 Whole-body optical imaging of gene expression and uses thereof
03/26/2003EP1294901A2 Novel proteases
03/26/2003EP1294895A2 Calpain protease 12
03/26/2003EP1294888A2 Interferon-like protein zcyto21
03/26/2003EP1294885A2 B7-like molecules and uses thereof
03/26/2003EP1294884A2 Secretion and trafficking molecules
03/26/2003EP1294883A2 Human extracellular matrix (ecm)-related tumor marker
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294881A2 Control of metabolism with compositions of the human 2-oxoglutarate carrier
03/26/2003EP1294879A2 Thymic stromal lymphopoietin receptor molecules and uses thereof
03/26/2003EP1294877A2 Cgi-69 compositions and methods of use
03/26/2003EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use
03/26/2003EP1294873A1 Tumour suppressor and uses thereof